We are a next-generation sequencing research facility working in partnership with leading researchers and institutes, contract research organizations, and drug discovery partners. Our new assay gives physicians expanded insight and actionable, progressive treatment options.

The PathGroup molecular diagnostics team is led by recognized experts in the field. Our new assays can be implemented and validated more rapidly than ever, and we provide comprehensive assessments, concise reports, exceptional accuracy, and lower costs.

We employ a dedicated team of Hematopathologists with certifications and expertise in Flow, IHC, Molecular pathology, and Cytogenetics. Our lab strictly follows all ASCO/NCCN guidelines to ensure responsible, appropriate, and accurate testing.

PathGroup provides physicians and their patients with comprehensive oncology diagnostic and clinical services that are accurate, fast, and personalized.